Latest VG Life Sciences Inc. (VGLS) Headlines VG Life

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest VG Life Sciences Inc. (VGLS) Headlines

VG Life Sciences, Inc. Increases Authorized Shares
GlobeNewswire - Thu Jan 02, 11:15PM CST
VG Life Sciences, Inc., (OTC Pink: VGLS) a biotechnology company. Pursuant to a vote of the holders having a majority of the votes of the Company on December 31, 2013, the number of authorized shares of Common Stock of the Company has been increased to 150,000,000.

VG Life Sciences, Inc. December 2013 Shareholder Letter
GlobeNewswire - Wed Dec 18, 12:12AM CST
VG Life Sciences, Inc., VGLS (formerly known as Viral Genetics) is a Santa Barbara, California-based biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 50 US and international patents and pending patents protecting its exclusive biotech platform technologies. Today the Company posted on its website (www.vglifesciences.com) the following December 2013 Shareholder Letter:

VG Life Sciences, Inc. Update on Phase I Cancer Study
PR Newswire - Fri Dec 13, 5:00AM CST
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.

VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies
PR Newswire - Mon Nov 04, 5:00AM CST
VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

US Patent Office Issues Patent for VG Life Sciences' Peptide for HIV Treatment
PR Newswire - Thu Oct 31, 5:00AM CDT
VG Life Sciences, Inc. is a publicly traded (VGLS) biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

VG Life Sciences Starts Prior Year Audit to Increase Financial Accountability
PR Newswire - Wed Oct 16, 5:00AM CDT
VG Life Sciences, Inc. (VGLS) is a publicly traded biotechnology company focused on developing treatments for patients suffering autoimmune and infectious diseases.

VG Energy Chief Scientist Awarded $200,000 AgriLife Grant to Study Lipid Secretion
PR Newswire - Thu Aug 08, 6:50PM CDT
VG Energy, an agricultural biotech company and wholly owned subsidiary of publicly traded VG Life Sciences Inc. (VGLS), announces today a $200,000 competitive grant from the Texas A&M AgriLife Research BioEnergy Initiatives Program for testing oil secretion technology.

VG Life Sciences, Inc. Reports on Scientific Advancements: Completion of Third Cohort of Phase I Clinical Trial; Grant from the American Heart Association; UniQuest Reports on LipidMax
PR Newswire - Thu Jul 25, 5:00AM CDT
SANTA BARBARA, Calif., July 25, 2013 /PRNewswire/--- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces today several advancements as it relates to its scientific advancements

VG Life Sciences, Inc. Announces Management Changes
PR Newswire - Thu Jul 18, 7:30AM CDT
VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces alterations in its corporate management and management structure.

VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
PR Newswire - Thu May 23, 10:24AM CDT
VG Energy, an agricultural biotech company, announces today a strategic alliance with DAK Renewable Research to conduct field trials using LipidMax to increase the corn oil yield. VG Energy is a majority owned subsidiary of VG Life Sciences, Inc. (OTC Pink: VGLS).

VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
PR Newswire - Thu Apr 04, 7:03AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today positive results from stage two of its Pre-IND Phase I Study to test tolerability and toxicity in patients with advanced stage solid tumors. The study, which is ongoing in patients with refractory or relapsed solid tumors, examines the safety and efficacy of hydroxychloroquine (HCQ), developed with VGLS' proprietary metabolic disruption technology (MDT), in combination with sorafenib (marketed as Nexavar®), which was co-developed by Bayer AG and Onyx Pharmaceuticals.

VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
PR Newswire - Fri Mar 22, 8:00AM CDT
VG Life Sciences, Inc. (OTC Pink: VGLS), a biotechnology company focused on leveraging its innovative platform technologies for the discovery and development of drug therapies for cancer, infectious disease, and inflammation, announced today that it has signed a two-year commitment to provide funding toward the operational needs of the company from current investor MedBridge, LLC, a leading provider of development, turnaround, partnership advising and revenue cycle management services for the medical and healthcare industries. During this period, MedBridge will also provide full administrative support for VG Life Sciences, allowing the company to focus on clinical development of its therapeutic pipeline.

VG Life Sciences Subsidiary, VGEnergy, Hires Chief Science Advisor
Business Wire - Thu Feb 28, 7:30AM CST
VG Life Sciences (OTC Pink: VGLS) announces that Martin B. Dickman, Ph.D., has joined its subsidiary VGEnergy, as Chief Science Advisor. In concert with the company's Board of Directors, Dr. Dickman will enhance the scientific rigor of the company's alternative energy core technology platform and expand development of a pipeline of products that enhance the lipid and sugar production in emerging market sectors, such as algal biofuels, and significantly, in more mature and much larger markets, such as corn and sugar cane.

VG Life Sciences Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar) Combined with Hydroxychloroquine
Business Wire - Thu Jan 31, 7:30AM CST
--Company Proceeds to Second Set of Patients

VG Life Sciences Expands Ovarian Cancer Trial; Approved to Study Treatment of Breast, Colon, Lung, Liver and Pancreas Cancer
Business Wire - Mon Jan 14, 3:06PM CST
VG Life Sciences (OTC Pink: VGLS), has received approval from the Institutional Review Board of the University of Texas Health Science Center San Antonio to expand the types of cancers being studied in the Company's ongoing physician-initiated Phase 1 clinical trial. The IRB action allows the study to immediately broaden scope to the treatment of all solid tumors, which includes a wide and diverse range of cancer types including breast, colon, lung, liver and pancreas cancer. Effective immediately, principal investigator Dr. Tyler Curiel will begin screening patients with all solid tumors to study the safety of hydroxychloroquine (HCQ) in combination with sorafenib (marketed as Nexevar(TM) by Bayer AG). VG Life Sciences holds the exclusive worldwide license to the body of patents underlying the use of MDT compounds in the treatment of cancers.

VG Life Sciences Inc. (VGLS) Stock Research Links

VGLS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 89

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 302

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 188

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 57

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 103

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading

Top 5 Most Recently Viewed Articles

FMC Corporation Faces Class Action Suit for Securities Fraud

Updated Category News Views 229

FMC Corporation Faces Class Action Suit for Securities Fraud The Rosen Law Firm, a prominent global firm advocating for investor rights, has initiated a class action lawsuit on behalf of purchasers of FMC Corporation (NYSE: FMC) securities. This lawsuit encompasses transactions made between specific dates in 2023 and 2025, referred to as the "Class Period." A prior...

Continue Reading
Verde Resources' BioAsphalt™ Demonstrates Carbon Sequestration Potential

Updated Category News Views 210

Verde's Innovative BioAsphalt™ Delivers Promising Validation Verde Resources Inc. (OTCQB: VRDR), a pioneering entity focused on sustainable infrastructure solutions, is proud to announce remarkable initial validation of its Biochar-Asphalt technology. This breakthrough was showcased at a renowned test track, highlighting the material's capabilities in sequestering...

Continue Reading
REGENXBIO Conference Call to Reveal Q3 Financial Insights

Updated Category News Views 71

REGENXBIO to Host a Key Conference Call REGENXBIO Inc. (NASDAQ: RGNX) has announced an important conference call aimed at discussing its financial results for the recently concluded third quarter. The call is scheduled for a weekday afternoon, at 4:30 p.m. ET. Participants can expect a thorough discussion on the financial performance that was achieved by REGENXBIO during...

Continue Reading
AppFolio Celebrates Ranking Among Fortune's Future 50 List

Updated Category News Views 256

AppFolio's Recent Achievements Highlight Company Growth AppFolio, the technology leader transforming the real estate sector, recently announced exciting news regarding its recognition by Fortune magazine. The company has been honored with a spot on Fortune's prestigious Future 50 and Best Workplaces in Technology lists. This acknowledgment underlines AppFolio's commitment...

Continue Reading
NDBN Teams Up with CareSource to Combat Diaper Shortage

Updated Category News Views 91

Introduction to the New Partnership The National Diaper Bank Network (NDBN) has formed a significant partnership with CareSource, a managed care organization renowned for its commitment to health and wellness. This collaboration aims to alleviate diaper need across the nation, providing essential support to families facing financial challenges. The Scope of Diaper Need in...

Continue Reading